DEVELOPING A BETTER THERAPEUTIC CONTACT LENS
Myopia progression in children is a major and growing problem worldwide. It is a condition in which a child’s nearsightedness rapidly and increasingly worsens over time. While scientists are not certain what has caused this problem to grow so quickly in recent years, the leading theories suggest that factors such as spending more time doing close-up work, reduced time spent outdoors, and genetics may be contributing to this phenomenon.
If left untreated, it can lead to serious vision issues in later life, such as glaucoma, retinal detachment, and myopic macular degeneration. Currently, it is a particular problem in China and other parts of Asia, where it is estimated that up to 90% of children have myopia. However, it is also a rapidly growing problem in the United States and other parts of the world. The current market size for myopia control is significant, with the global market expected to reach $4.3 billion by 2025.
Traditional multifocal contact lenses are a common treatment option.
However, the current generation of contact lenses are only partially effective, and a significant opportunity exists for a contact lens that is more purpose-built to slow down myopia progression.
Clerio Vision is at the forefront of research and development in this area, using our LIRIC technology to create contact lenses that have the potential to be more effective at slowing down this condition.
With the myopia epidemic affecting millions of children worldwide, a more effective contact lens could have a significant impact on public health and help prevent a generation of children from experiencing major vision issues later in life.